The use of an L3 and/or L5 source as a vaccine or as a diagnostic for a parasitic disease

Details for Australian Patent Application No. 2010317962 (hide)

Owner Laboratorios LETI, S.L.

Inventors Alonso - Bedate, Carlos; Soto Alvarez, Manuel; Ramirez Garcia, Laura

Agent Griffith Hack

Pub. Number AU-A-2010317962

PCT Pub. Number WO2011/058137

Priority 61/261,020 13.11.09 US; 09175929.0 13.11.09 EP

Filing date 12 November 2010

Wipo publication date 19 May 2011

International Classifications

C07K 14/44 Peptides having more than 20 amino acids

A61K 39/008 Medicinal preparations containing antigens or antibodies - Leishmania antigens

G01N 33/569 Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/058137 Priority application(s): WO2011/058137

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010317963-A panel for a container, a container provided with such container and a method for making same

2010317960-Switch system and method for the monitoring of virtual optical paths in an Optical Burst Switched (OBS) communication network